Arginine methylation-dependent cGAS stability promotes non-small cell lung cancer cell proliferation

Cancer Lett. 2024 Apr 1:586:216707. doi: 10.1016/j.canlet.2024.216707. Epub 2024 Feb 7.

Abstract

Cyclic GMP-AMP synthase (cGAS), promotes non-small cell lung cancer (NSCLC) cell proliferation. However, the specific mechanisms of cGAS-mediated NSCLC cell proliferation are largely unknown. In this study, we found asymmetric dimethylation by protein arginine methyltransferase 1 (PRMT1) at R127 of cGAS. This facilitated the binding of deubiquitinase USP7 and contributed to deubiquitination and stabilization of cGAS. PRMT1-and USP7-dependent cGAS stability, which also played a pivotal role in accelerating NSCLC cell proliferation through activating AKT pathway. We validated that the expression of cGAS and PRMT1 were positive correlated in human non-small cell lung cancer samples. Our study demonstrates a unique mechanism for managing cGAS stability by arginine methylation and indicates that PRMT1-cGAS-USP7 axis is a potential therapeutic target for NSCLC.

Keywords: AKT pathway; Arginine methylation; NSCLC; PRMT1; cGAS.

MeSH terms

  • Arginine
  • Carcinoma, Non-Small-Cell Lung* / genetics
  • Cell Proliferation
  • Humans
  • Lung Neoplasms* / genetics
  • Methylation
  • Protein-Arginine N-Methyltransferases / genetics
  • Protein-Arginine N-Methyltransferases / metabolism
  • Repressor Proteins / metabolism
  • Ubiquitin-Specific Peptidase 7 / metabolism

Substances

  • Arginine
  • PRMT1 protein, human
  • Protein-Arginine N-Methyltransferases
  • Repressor Proteins
  • Ubiquitin-Specific Peptidase 7
  • USP7 protein, human
  • cGAS protein, human